{"id":"fominoben","rwe":[{"pmid":"2943646","year":"1986","title":"[Effects of naloxone on the cough depressant activities of antitussive drugs].","finding":"","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","studyType":"Clinical Study"},{"pmid":"2865824","year":"1985","title":"Other forms of treatment for anxiety.","finding":"","journal":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","studyType":"Clinical Study"},{"pmid":"3158563","year":"1985","title":"Effects of the antitussive fominoben (PB89) on hypoxia in chronic obstructive lung disease: comparison with dextromethorphan using a double-blind method.","finding":"","journal":"The Journal of international medical research","studyType":"Clinical Study"},{"pmid":"6087374","year":"1984","title":"Anticonvulsant actions of fominoben: possible involvement of benzodiazepine receptors.","finding":"","journal":"Pharmacology, biochemistry, and behavior","studyType":"Clinical Study"},{"pmid":"6142823","year":"1984","title":"Anxiolytic-like properties of fominoben.","finding":"","journal":"European journal of pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Antitussive Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Respiratory System Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"terion","offLabel":[],"synonyms":["noleptan","fominoben hydrochloride","fominoben","terion","fominoben HCl"],"timeline":[],"approvals":[],"brandName":"Terion","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and proteins or receptors are like keys. Terion is like a key that fits into a specific lock, allowing it to turn and unlock a cellular process that helps to treat a particular disease or condition. This process can help to restore balance and health to the body.","oneSentence":"Terion works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Terion's mechanism of action is likely to involve the interaction with specific biological molecules, such as enzymes, receptors, or ion channels, to produce a therapeutic effect. This interaction can lead to changes in cellular signaling pathways, gene expression, or other downstream effects that ultimately contribute to the drug's therapeutic benefits."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1234","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FOMINOBEN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:37:50.549608","biosimilars":[],"competitors":[],"genericName":"fominoben","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"006007","UNII":"TJ2KK6NYJS","CHEBI":"CHEBI:135639","INN_ID":"3260","RXNORM":"183875","UMLSCUI":"C0026561","ChEMBL_ID":"CHEMBL1697837","KEGG_DRUG":"D01483","DRUGBANK_ID":"DB08968","PUBCHEM_CID":"3407","SECONDARY_CAS_RN":"24600-36-0","MESH_SUPPLEMENTAL_RECORD_UI":"C073322"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":48,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1986 Jun","pmid":"2943646","title":"[Effects of naloxone on the cough depressant activities of antitussive drugs].","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica"},{"date":"1985 Oct 26","pmid":"2865824","title":"Other forms of treatment for anxiety.","journal":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde"},{"date":"1985","pmid":"3158563","title":"Effects of the antitussive fominoben (PB89) on hypoxia in chronic obstructive lung disease: comparison with dextromethorphan using a double-blind method.","journal":"The Journal of international medical research"},{"date":"1984 Jul","pmid":"6087374","title":"Anticonvulsant actions of fominoben: possible involvement of benzodiazepine receptors.","journal":"Pharmacology, biochemistry, and behavior"},{"date":"1984 Jan 27","pmid":"6142823","title":"Anxiolytic-like properties of fominoben.","journal":"European journal of pharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Terion, also known as FOMINOBEN, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this drug's properties and potential uses.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}